Profound Medical Corp. cotiza a 7.25 USD y tiene una capitalización bursátil de $265M. En los últimos 12 meses ha facturado $19M con un margen de flujo de caja libre del -238.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven tra…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.26 | $-0.19 | $-0.27 |
| Estimado | $-0.27 | $-0.24 | $-0.25 | $-0.27 |
| Sorpresa | — | -8.3% | +24.0% | +0.0% |
| Métrica | PROF | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 70.8% | 57.0% | +13.7% |
| Operating Margin | -256.3% | -38.6% | -217.6% |
| Net Margin | -264.4% | -33.6% | -230.9% |
| FCF Margin | -238.4% | -13.9% | -224.6% |
| ROE | -64.1% | -40.4% | -23.7% |
| ROA | -55.0% | -32.0% | -22.9% |
| Current Ratio | 12.52 | 2.84 | +9.68 |
| Debt / Equity | 0.07 | 0.28 | -0.21 |